方盛制药：小儿荆杏止咳颗粒的疗效明显优于安慰剂

证券日报网07-15

登录新浪财经APP 搜索【信披】查看更多考评等级证券日报网7月15日讯，方盛制药在接受调研者提问时表示，2026年4月28日，公司研发的小儿荆杏止咳颗粒取得了成人急性气管-支气管炎（风寒化热证）的III期临床试验总结报告。试验数据显示，小儿荆杏止咳颗粒的疗效明显优于安慰剂，已达到预期研究主要终点。支气管炎严重程度评分数据显示，本品可明显改善急性气管-支气管炎严重程度。中医证候评分数据显示，本品...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2651461655?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-15 21:35","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2651461655","market":"hk","top_or_hot":-1,"title":"方盛制药：小儿荆杏止咳颗粒的疗效明显优于安慰剂","media":"证券日报网","content":"<div>\n<p>登录新浪财经APP 搜索【信披】查看更多考评等级\n证券日报网7月15日讯 ，方盛制药在接受调研者提问时表示，2026年4月28日，公司研发的小儿荆杏止咳颗粒取得了成人急性气管-支气管炎（风寒化热证）的III期临床试验总结报告。试验数据显示，小儿荆杏止咳颗粒的疗效明显优于安慰剂，已达到预期研究主要终点。支气管炎严重程度评分数据显示，本品可明显改善急性气管-支气管炎严重程度。中医证候评分数据显示，本品...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/relnews/cn/2026-07-15/doc-inihxaeu7918897.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>方盛制药：小儿荆杏止咳颗粒的疗效明显优于安慰剂</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n方盛制药：小儿荆杏止咳颗粒的疗效明显优于安慰剂\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-15 21:35 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/relnews/cn/2026-07-15/doc-inihxaeu7918897.shtml><strong>证券日报网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>登录新浪财经APP 搜索【信披】查看更多考评等级\n证券日报网7月15日讯 ，方盛制药在接受调研者提问时表示，2026年4月28日，公司研发的小儿荆杏止咳颗粒取得了成人急性气管-支气管炎（风寒化热证）的III期临床试验总结报告。试验数据显示，小儿荆杏止咳颗粒的疗效明显优于安慰剂，已达到预期研究主要终点。支气管炎严重程度评分数据显示，本品可明显改善急性气管-支气管炎严重程度。中医证候评分数据显示，本品...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/relnews/cn/2026-07-15/doc-inihxaeu7918897.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603998","symbol_name":"方盛制药","start_time":0,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-15/doc-inihxaeu7918897.shtml","article_id":"2651461655","we_media_id":null,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-15/doc-inihxaeu7918897.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2651461655","pubTimestamp":1784122500,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"证券日报网7月15日讯 ，方盛制药在接受调研者提问时表示，2026年4月28日，公司研发的小儿荆杏止咳颗粒取得了成人急性气管-支气管炎 的III期临床试验总结报告。试验数据显示，小儿荆杏止咳颗粒的疗效明显优于安慰剂，已达到预期研究主要终点。目前，公司已向国家药品监督管理局提出成人适用症相关事项补充申请并收到《受理通知书》，后续药品研发注册如有新的进展，公司将严格按照有关法律法规的规定及时履行信息披露义务。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603998":"方盛制药","BK0060":"抗癌","BK0239":"医药制造"},"translate_title":"Fangsheng Pharmaceutical: The efficacy of Xiaoer Jingxing Zhike Granules is significantly better than that of placebo","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603998":1.5},"content_text":"登录新浪财经APP 搜索【信披】查看更多考评等级\n证券日报网7月15日讯 ，方盛制药在接受调研者提问时表示，2026年4月28日，公司研发的小儿荆杏止咳颗粒取得了成人急性气管-支气管炎（风寒化热证）的III期临床试验总结报告。试验数据显示，小儿荆杏止咳颗粒的疗效明显优于安慰剂，已达到预期研究主要终点。支气管炎严重程度评分数据显示，本品可明显改善急性气管-支气管炎严重程度。中医证候评分数据显示，本品可有效改善咳嗽、咳痰、咽痛、恶风、恶寒、咽痒、胸闷、口渴等中医单项症状。咳嗽视觉模拟评分较基线的变化、咳嗽缓解时间及咳嗽消失时间数据显示，本品可加快病情缓解，缩短疾病病程，促进疾病痊愈（详见公司2026-030号公告）。目前，公司已向国家药品监督管理局提出成人适用症相关事项补充申请并收到《受理通知书》，后续药品研发注册如有新的进展，公司将严格按照有关法律法规的规定及时履行信息披露义务。\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2651461655","isCrawlerRequest":true}